Companies /Healthcare
Oscar Health Inc - Class A
NYSE: OSCR Healthcare Plans
$29.85
▼ $1.49 (−4.74%) today
Markets closed · 6:14pm ET

Oscar Health (OSCR) Q3 2026 Earnings

Reported Nov 5, 2026, 6:09am ET · SEC source
$0.49
Beat +382.58%
EPS · est. $-0.17 GAAP

Revenue included a $250 million benefit from updated risk adjustment estimates; quarter also included $42 million of favorable prior period development.

$5.1B
Beat +8.93%
Revenue · est. $4.7B
3 quarters
Consecutive EPS beats

How Did OSCR Stock React to Q3 2026 Earnings?

% change · around the report
−18%−12%−6%0Nov 5Nov 6report 6:09am ETearnings−3.7%−15.8%
−18%−12%−6%0Nov 5Nov 6earnings−3.7%−15.8%
OSCR −15.8%S&P 500 −3.7%
−18%−12%−6%0Nov 5Nov 6report 6:09am ETearnings−4.2%−15.8%
−18%−12%−6%0Nov 5Nov 6earnings−4.2%−15.8%
OSCR −15.8%NASDAQ −4.2%
−15%−10%−5%0Nov 4Nov 12report 6:09am ETearnings−1.1%−13.8%
−15%−10%−5%0Nov 4Nov 12earnings−1.1%−13.8%
OSCR −13.8%S&P 500 −1.1%
−18%−12%−6%0Nov 4Nov 12report 6:09am ETearnings+0.4%−13.8%
−18%−12%−6%0Nov 4Nov 12earnings+0.4%−13.8%
OSCR −13.8%NASDAQ +0.4%
−5.71%
Day of report
−7.63%
Next session
−3.74%
One week

Did OSCR Beat Earnings? Q3 2026 Results

Yes. Oscar Health reported Q3 2026 earnings of $0.49 a share on Nov 5, 2026, beating the $-0.17 consensus estimate by 382.6%. Revenue was $5.1B against a $4.7B estimate.

Oscar Health delivered a sharp swing to profitability in the third quarter of 2026, posting GAAP earnings of $0.49 per diluted share against a consensus estimate of negative $0.17, a beat of 382.58%, compared with a loss of $0.53 per share a year earlier. Revenue surged 72.1% year over year to $5.14 billion, clearing the $4.72 billion consensus by 8.93%, driven by rate increases and membership growth that pushed effectuated enrollment to roughly 2.69 million. The quarter's results included a $250 million benefit from updated risk adjustment estimates reflecting favorable risk score development relative to the market, as well as $42 million of favorable prior period development; both items are embedded in the GAAP figures. The medical loss ratio improved to 84.0% from 88.5%, underscoring the pricing discipline management has emphasized all year. Looking ahead, Oscar raised its full-year earnings from operations outlook to $850 million to $950 million, the third increase this year, while lifting its total revenue guidance to $19.0 to $19.3 billion, with management citing plans to expand into additional states and grow market share into 2027.

Key Takeaways
  • Rate increases and higher membership drove revenue to ~$5.1 billion from $3.0 billion
  • $250 million revenue benefit from updated risk adjustment estimates due to favorable risk score development and modestly favorable market morbidity
  • MLR improved to 84.0% from 88.5%, driven by disciplined pricing
  • $42 million favorable prior period development (vs $84 million a year ago)
  • SG&A ratio fell to 14.0% from 17.5% on lower risk adjustment as a percentage of premium, fixed cost leverage and expense discipline
  • Investment income rose to $91.0 million from $53.2 million

“Oscar Health is on track to deliver the strongest year of financial performance in our history, and we are raising our earnings from operations outlook for a third time.”

Oscar Health CEO, on the earnings call

What Is Oscar Health's Outlook?

Oscar raised its full-year 2026 outlook. Total revenue is now expected at $19.0–$19.3 billion (prior $18.7–$19.0 billion). Medical loss ratio is expected at 80.5%–81.5% (prior 81.0%–82.0%) and SG&A expense ratio at 15.1%–15.6% (prior 15.6%–16.1%). Earnings from operations are expected at $850–$950 million (prior $600–$800 million), the third raise this year. Management expects to grow market share and expand margin in 2027.

OSCR YoY Financials

Q3 2026 vs Q3 2025 · SEC filings Q3 2025 Q3 2026
$0$2.0B$4.0B$3.0B$5.1BRevenue$52.7M$178.0MOperating Income$52.0M$167.3MNet Income
$0$2.0B$4.0BRevenueOperating IncomeNet Income
OSCR income statement, Q3 2026 versus Q3 2025
Metric Q3 2026 Q3 2025 Year over year
Revenue $5.1B $3.0B +72.1%
Operating Income $178.0M $52.7M +237.7%
Net Income $167.3M $52.0M +221.7%

OSCR Revenue by Segment

Individual & Small Group

When Does Oscar Health Report Next?

Expected report date
After the close
Release timing

Figures from SEC filings and company reports. Not investment advice.